tm logo

Monitor this mark

View On USPTO

RIXUBIS
Live/Registered
REGISTERED AND RENEWED

on 20 Jun 2024

Last Applicant/ Owned by

BAXALTA INCORPORATED

1200 LAKESIDE DRIVE

BANNOCKBURN

IL

60015

Serial Number

85899949 filed on 10th Apr 2013

Registration Number

4544829 registered on 03rd Jun 2014

in the Principal Register

Correspondent Address

Karl M. Zielaznicki, Esq.

Karl M. Zielaznicki, Esq. Troutman Sanders LLP

c/o IP Services NYC

New York, NY 10022

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

RIXUBIS

pharmaceutical preparations for the treatment of hemophilia

Classification Information

Class [005]
Pharmaceutical Products

pharmaceutical preparations for the treatment of hemophilia

First Use Date in General

02th Oct 2013

First Use Date in Commerce

02th Oct 2013

Mark Details

Serial Number

No 85899949

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 250214001007

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
20th Jun 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
20th Jun 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
20th Jun 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
18th Jun 2024TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
15th Jun 2024POST REGISTRATION ACTION MAILED - SEC. 8 & 9
15th Jun 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
13th Mar 2024TEAS SECTION 8 & 9 RECEIVED
03rd Jun 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01st Mar 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01st Mar 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL